Comerica Bank’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-31,834
| Closed | -$435K | – | 2366 |
|
|
2020
Q3 | $435K | Sell |
31,834
-3,832
| -11% | -$36.4K | ﹤0.01% | 1967 |
|
|
2020
Q2 | $313K | Buy |
35,666
+2,684
| +8% | +$20.5K | ﹤0.01% | 2037 |
|
|
2020
Q1 | $265K | Buy |
32,982
+1,126
| +4% | +$9.92K | ﹤0.01% | 1999 |
|
|
2019
Q4 | $289K | Sell |
31,856
-134
| -0.4% | -$1.46K | ﹤0.01% | 2083 |
|
|
2019
Q3 | $345K | Sell |
31,990
-92
| -0.3% | -$968 | ﹤0.01% | 2021 |
|
|
2019
Q2 | $278K | Sell |
32,082
-2,140
| -6% | -$23.1K | ﹤0.01% | 2094 |
|
|
2019
Q1 | $442K | Buy |
34,222
+846
| +3% | +$12.6K | ﹤0.01% | 1941 |
|
|
2018
Q4 | $507K | Sell |
33,376
-204
| -0.6% | -$3.89K | ﹤0.01% | 1862 |
|
|
2018
Q3 | $755K | Sell |
33,580
-2,623
| -7% | -$59.7K | 0.01% | 1716 |
|
|
2018
Q2 | $798K | Sell |
36,203
-51
| -0.1% | -$1.13K | 0.01% | 1760 |
|
|
2018
Q1 | $720K | Hold |
36,254
| – | – | 0.01% | 1771 |
|
|
2017
Q4 | $520K | Sell |
36,254
-853
| -2% | -$12.9K | ﹤0.01% | 1908 |
|
|
2017
Q3 | $586K | Buy |
37,107
+452
| +1% | +$8.42K | ﹤0.01% | 1846 |
|
|
2017
Q2 | $728K | Sell |
36,655
-1,392
| -4% | -$27.6K | 0.01% | 1707 |
|
|
2017
Q1 | $936K | Buy |
38,047
+1,648
| +5% | +$39.5K | 0.01% | 1637 |
|
|
2016
Q4 | $837K | Buy |
36,399
+1,764
| +5% | +$52.7K | 0.01% | 1667 |
|
|
2016
Q3 | $845K | Sell |
34,635
-65
| -0.2% | -$1.63K | 0.01% | 1588 |
|
|
2016
Q2 | $885K | Sell |
34,700
-704
| -2% | -$16.1K | 0.01% | 1565 |
|
|
2016
Q1 | $901K | Buy |
+35,404
| New | +$840K | 0.01% | 1524 |
|
Comerica Bank's AMAG Position: Q4 2020 in Review
Comerica Bank sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 31,834 shares — an estimated $435K sold.
Comerica Bank first reported a position in AMAG in Q1 2016 and held it in 19 quarters. The position peaked at $936K in Q1 2017. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Comerica Bank reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Comerica Bank sold 31,834 AMAG Pharmaceuticals shares in Q4 2020, an estimated $435K.
- Comerica Bank first reported a position in AMAG Pharmaceuticals in Q1 2016 and held it in 19 quarters.
- Comerica Bank's AMAG Pharmaceuticals position peaked at $936K in Q1 2017.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Comerica Bank's 13F filing for Q4 2020, filed 28 Jan 2021.